Mehdi Rajabi
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents 9
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 4
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 4
- Organic Chemistry top 5%
- Synthesis and biological activity 10
- Molecular Biology top 10%
- Angiogenesis and VEGF in Cancer 4
-
- Cell Adhesion Molecules Research 5
-
- Synthesis of Organic Compounds 5
-
- Essential Oils and Antimicrobial Activity 4
- Co-authors
- Shaker A. MousaMathangi SrinivasanMohammad A. KhalilzadehDan ShuPeixuan GuoYi ShuMohamed Nadjib BoukhatemEnzo Santaniello
- Journals
- SHILAP Revista de lepidopterología (1 paper)Blood (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesIranItaly
In The Last Decade
Mehdi Rajabi
52 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Toxicology 80
- Biomaterials 205
- Cancer Research 235
- Organic Chemistry 420
- Molecular Biology 960
Countries citing papers authored by Mehdi Rajabi
This map shows the geographic impact of Mehdi Rajabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehdi Rajabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehdi Rajabi more than expected).
Fields of papers citing papers by Mehdi Rajabi
This network shows the impact of papers produced by Mehdi Rajabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehdi Rajabi. The network helps show where Mehdi Rajabi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mehdi Rajabi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2020 | 28 | |
| 3 | 2020 | 53 | |
| 4 | 2020 | 14 | |
| 5 | 2020 | 17 | |
| 6 | 2020 | 55 | |
| 7 | 2019 | 75 | |
| 8 | 2019 | 23 | |
| 9 | 2018 | 49 | |
| 10 | 2018 | 1 | |
| 11 | The Role of Angiogenesis in Cancer Treatmentbreakdown → | 2017 | 502 |
| 12 | 2015 | 109 | |
| 13 | 2014 | 6 | |
| 14 | 2013 | 204 | |
| 15 | 2013 | 12 | |
| 16 | 2011 | 15 | |
| 17 | 2011 | 4 | |
| 18 | 2011 | 15 | |
| 19 | 2010 | 25 | |
| 20 | 2008 | 85 |
About Mehdi Rajabi
Mehdi Rajabi is a scholar working on Toxicology, Immunology and Allergy and Organic Chemistry, having authored 54 papers that have together received 1.9k indexed citations. Recurring topics across this work include Synthesis and biological activity (10 papers), Bioactive Compounds and Antitumor Agents (9 papers), Cell Adhesion Molecules Research (5 papers), Synthesis of Organic Compounds (5 papers), Nanoparticle-Based Drug Delivery (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Essential Oils and Antimicrobial Activity (4 papers). The work is most often cited by research in Toxicology (80 citations), Biomaterials (205 citations) and Cancer Research (235 citations). Mehdi Rajabi has collaborated with scholars based in United States, Iran and Italy. Frequent co-authors include Shaker A. Mousa, Mathangi Srinivasan, Mohammad A. Khalilzadeh, Dan Shu, Peixuan Guo, Yi Shu, Mohamed Nadjib Boukhatem, Enzo Santaniello, Zinatossadat Hossaini and Farzin Haque. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.